Amedeo Smart

Free Medical Literature Service


 

Amedeo

HIV Infection

  Free Subscription

15.08.2022

6 AIDS
3 AIDS Res Hum Retroviruses
1 Antimicrob Agents Chemother
1 BMC Pediatr
1 BMJ
2 Br J Haematol
2 Clin Infect Dis
7 HIV Med
2 J Acquir Immune Defic Syndr
1 J Infect Dis
1 J Med Virol
2 J Virol
1 JAMA
1 Lancet
2 Lancet Infect Dis
2 MMWR Morb Mortal Wkly Rep
2 N Engl J Med
1 Nat Med
1 Nat Rev Neurol
2 Nature
1 Neurology
7 PLoS One
1 PLoS Pathog
1 Proc Natl Acad Sci U S A



    AIDS

  1. HERMANS LE, Ter Heine R, Schuurman R, Tempelman HA, et al
    A randomised study of intensified ART monitoring versus standard-of-care for prevention of drug resistance and ART switch: week 96 results of the ITREMA trial.
    AIDS. 2022 Aug 11. pii: 00002030-990000000-00083.
    >> Share

  2. LAKE JE, Wang R, Barrett BW, Bowman E, et al
    Trans women have worse cardiovascular biomarker profiles than cisgender men independent of hormone use and HIV serostatus.
    AIDS. 2022 Aug 11. pii: 00002030-990000000-00081.
    >> Share

  3. DUARTE M, Ma Y, Noworolski SM, Korn N, et al
    Controlled Attenuation Parameter Accurately Detects Liver Steatosis in People Living with HIV.
    AIDS. 2022 Aug 11. pii: 00002030-990000000-00082.
    >> Share

  4. JAIN JP, Sheira LA, Frongillo EA, Neilands TB, et al
    Mechanisms linking gender-based violence to worse HIV treatment and care outcomes among women in the United States.
    AIDS. 2022 Aug 11. pii: 00002030-990000000-00080.
    >> Share

  5. SPIELER G, Westfall AO, Long DM, Cherrington A, et al
    Trends in diabetes incidence and associated risk factors among people living with HIV in the current treatment era, 2008-2018.
    AIDS. 2022 Aug 11. pii: 00002030-990000000-00084.
    >> Share

  6. NUNES MC, Jones S, Ditse Z, da Silva K, et al
    Maternal-foetal transfer of SARS-CoV-2 antibodies among women with and those without HIV infection.
    AIDS. 2022 Aug 11. pii: 00002030-990000000-00085.
    >> Share


    AIDS Res Hum Retroviruses

  7. KOUAMOU V, Machekano R, Mapangisana T, Maposhere C, et al
    Tenofovir, Lamivudine and Dolutegravir (TLD) among Rural Adolescents in Zimbabwe, a Cautionary Tale.
    AIDS Res Hum Retroviruses. 2022 Aug 12. doi: 10.1089/AID.2021.0140.
    >> Share

  8. FENG L, Chen T, Zhang J, Wang Q, et al
    Clinical characteristics and outcomes of chronic kidney disease in people living with HIV in a resource limited centre of central China.
    AIDS Res Hum Retroviruses. 2022 Aug 11. doi: 10.1089/AID.2022.0009.
    >> Share

  9. YAGER J, Brooks KM, Brothers J, Mulligan K, et al
    Pharmacokinetics of emtricitabine/tenofovir disoproxil fumarate among transgender adolescents and young adults without HIV receiving gender affirming hormones.
    AIDS Res Hum Retroviruses. 2022 Aug 9. doi: 10.1089/AID.2022.0043.
    >> Share


    Antimicrob Agents Chemother

  10. PHAM MM, Podany AT, Mwelase N, Supparatpinyo K, et al
    Population Pharmacokinetic Modeling and Simulation of Rifapentine Supports Concomitant Antiretroviral Therapy with Efavirenz and Non-Weight Based Dosing.
    Antimicrob Agents Chemother. 2022 Aug 9:e0238521. doi: 10.1128/aac.02385.
    >> Share


    BMC Pediatr

  11. RENCKEN G, Govender P, Uys CJE
    Neurobehavioural challenges experienced by HIV exposed infants: a study in South Africa.
    BMC Pediatr. 2022;22:479.
    >> Share


    BMJ

  12. MULKA L, Cassell J
    The changing face of monkeypox.
    BMJ. 2022;378:o1990.
    >> Share


    Br J Haematol

  13. JESSA R, Chien N, Villa D, Freeman CL, et al
    Clinicopathological characteristics and long-term outcomes of plasmablastic lymphoma in British Columbia.
    Br J Haematol. 2022 Aug 12. doi: 10.1111/bjh.18399.
    >> Share

  14. OGBENNA AA, Akinsete AM, Kalejaiye OO, Matthew OK, et al
    Reduction in seroprevalence of viral transfusion-transmitted infections in southwest Nigeria in children with sickle cell disease using an enhanced screening strategy.
    Br J Haematol. 2022;198:745-752.
    >> Share


    Clin Infect Dis

  15. BUNJUN R, Ramla TF, Jaumdally SZ, Noel-Romas L, et al
    Initiating Intramuscular Depot Medroxyprogesterone Acetate (DMPA-IM) Increases Frequencies of Th17-like Human Immunodeficiency Virus (HIV) Target Cells in the Genital Tract of Women in South Africa: A Randomized Trial.
    Clin Infect Dis. 2022 Aug 9. pii: 6658490. doi: 10.1093.
    >> Share

  16. PROSTY C, Hanula R, Levin Y, Bogoch II, et al
    Revisiting the Evidence Base for Modern Day Practice of the Treatment of Toxoplasmic Encephalitis: A Systematic Review and Meta-Analysis.
    Clin Infect Dis. 2022 Aug 9. pii: 6659053. doi: 10.1093.
    >> Share


    HIV Med

  17. GOODEN TE, Wang J, Zemedikun DT, Taylor S, et al
    A matched cohort study investigating premature, accentuated, and accelerated aging in people living with HIV.
    HIV Med. 2022 Aug 7. doi: 10.1111/hiv.13375.
    >> Share

  18. D'AMICO R, Cenoz Gomis S, Moodley R, Van Solingen-Ristea R, et al
    Compassionate use of long-acting cabotegravir plus rilpivirine for people living with HIV-1 in need of parenteral antiretroviral therapy.
    HIV Med. 2022 Aug 9. doi: 10.1111/hiv.13370.
    >> Share

  19. PERELLO R, Losada A, Chen J, Supervia A, et al
    Amphetamine-related intoxications in people living with HIV: An observational study in an emergency department in Barcelona (Spain) from 2018 to 2020.
    HIV Med. 2022 Aug 9. doi: 10.1111/hiv.13365.
    >> Share

  20. LIONS C, Laroche H, Mora M, Pialoux G, et al
    Missed opportunities for HIV pre-exposure prophylaxis among people with recent HIV infection: The French ANRS 95041 OMaPrEP study.
    HIV Med. 2022 Aug 9. doi: 10.1111/hiv.13367.
    >> Share

  21. NASREDDINE R, Yombi JC, Darcis G, Florence E, et al
    Efficacy, durability, and tolerability of dolutegravir/lamivudine and dolutegravir/rilpivirine for the treatment of HIV in a real-world setting in Belgium.
    HIV Med. 2022 Aug 8. doi: 10.1111/hiv.13373.
    >> Share

  22. NIKOLAICHUK M, Mocroft A, Wandeler G, Szlavik J, et al
    Use of contraindicated antiretroviral drugs in people with HIV/HCV coinfections receiving HCV treatment with direct-acting antivirals-Results from the EuroSIDA study.
    HIV Med. 2022 Aug 8. doi: 10.1111/hiv.13357.
    >> Share

  23. GARCIA YD, Urena FA, Carrion-Nessi FS, Diaz SY, et al
    HBV, HCV, or syphilis coinfection with HIV in pregnant women seen at the main hospital in the capital of Venezuela.
    HIV Med. 2022 Aug 7. doi: 10.1111/hiv.13372.
    >> Share


    J Acquir Immune Defic Syndr

  24. YOON H, Hemmige VS, Lee A, Conway-Pearson LS, et al
    Cryptococcal antigen screening and missed opportunities for earlier diagnosis among people with HIV and poor virologic control in the Bronx, N.Y.
    J Acquir Immune Defic Syndr. 2022 Aug 11. pii: 00126334-990000000-00087.
    >> Share

  25. WEISS F, von Both U, Rack-Hoch A, Sollinger F, et al
    HIV-Positive and Breastfeeding in High-Income Settings: 5-year Experience from a Perinatal Center in Germany.
    J Acquir Immune Defic Syndr. 2022 Aug 9. pii: 00126334-990000000-00088.
    >> Share


    J Infect Dis

  26. GARDNER AR, Ma Y, Bacchetti P, Price JC, et al
    Longitudinal Assessment of the Enhanced Liver Fibrosis Score in the Era of Contemporary HIV and Hepatitis C Virus Treatment.
    J Infect Dis. 2022 Aug 11. pii: 6650396. doi: 10.1093.
    >> Share


    J Med Virol

  27. JIANG X, Sharma PP, Rathi B, Ji X, et al
    Discovery of novel 1,2,4-triazole phenylalanine derivatives targeting an unexplored region within the interprotomer pocket of the HIV capsid protein.
    J Med Virol. 2022 Aug 10. doi: 10.1002/jmv.28064.
    >> Share


    J Virol

  28. JONES ST, Guo K, Cooper EH, Dillon SM, et al
    Altered Immunoglobulin Repertoire and Decreased IgA Somatic Hypermutation in the Gut during Chronic HIV-1 Infection.
    J Virol. 2022 Aug 8:e0097622. doi: 10.1128/jvi.00976.
    >> Share

  29. DUAN S, Yu X, Wang C, Meng L, et al
    Dominant Negative Mutants of Human Immunodeficiency Virus Type 1 Viral Infectivity Factor (Vif) Disrupt Core-Binding Factor Beta-Vif Interaction.
    J Virol. 2022 Aug 11:e0055522. doi: 10.1128/jvi.00555.
    >> Share


    JAMA

  30. KUEHN BM
    Reduced HIV Testing and Diagnoses During COVID-19 Pandemic.
    JAMA. 2022;328:519.
    >> Share


    Lancet

  31. TARIN-VICENTE EJ, Alemany A, Agud-Dios M, Ubals M, et al
    Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study.
    Lancet. 2022 Aug 8. pii: S0140-6736(22)01436.
    >> Share


    Lancet Infect Dis

  32. SCHWARTZ NG, Hernandez-Romieu AC, Annambhotla P, Filardo TD, et al
    Nationwide tuberculosis outbreak in the USA linked to a bone graft product: an outbreak report.
    Lancet Infect Dis. 2022 Aug 4. pii: S1473-3099(22)00425.
    >> Share

  33. NAZARETH J, Pan D, Martin CA, Barr I, et al
    Is the UK prepared for seasonal influenza in 2022-23 and beyond?
    Lancet Infect Dis. 2022 Aug 3. pii: S1473-3099(22)00503.
    >> Share


    MMWR Morb Mortal Wkly Rep

  34. O'SHEA J, Filardo TD, Morris SB, Weiser J, et al
    Interim Guidance for Prevention and Treatment of Monkeypox in Persons with HIV Infection - United States, August 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1023-1028.
    >> Share

  35. PHILPOTT D, Hughes CM, Alroy KA, Kerins JL, et al
    Epidemiologic and Clinical Characteristics of Monkeypox Cases - United States, May 17-July 22, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1018-1022.
    >> Share


    N Engl J Med

  36. HALL CS
    HIV Prevention and the 340B Drug Pricing Program.
    N Engl J Med. 2022;387:575-576.
    >> Share

  37. MARCUS JL, Killelea A, Krakower DS
    HIV Prevention and the 340B Drug Pricing Program. Reply.
    N Engl J Med. 2022;387:576.
    >> Share


    Nat Med

  38. DE BAETSELIER I, Van Dijck C, Kenyon C, Coppens J, et al
    Retrospective detection of asymptomatic monkeypox virus infections among male sexual health clinic attendees in Belgium.
    Nat Med. 2022 Aug 12. pii: 10.1038/s41591-022-02004.
    >> Share


    Nat Rev Neurol

  39. LEMPRIERE S
    Phagocytes linked to cognitive dysfunction in neuro-HIV.
    Nat Rev Neurol. 2022 Aug 8. pii: 10.1038/s41582-022-00706.
    >> Share


    Nature

  40. PADMA TV
    Long-lasting HIV prevention drug could be game changer - but who will pay?
    Nature. 2022 Aug 5. pii: 10.1038/d41586-022-02123.
    >> Share


  41. Preventive HIV drug shows urgent need for transparency on pricing.
    Nature. 2022;608:239.
    >> Share


    Neurology

  42. VAN GENDEREN JG, Chia C, Van den Hof M, Mutsaerts HJMM, et al
    Brain Differences in Adolescents Living With Perinatally Acquired HIV Compared to Adoption Status Match Controls: A Cross-Sectional Study.
    Neurology. 2022 Aug 8. pii: WNL.0000000000200946.
    >> Share


    PLoS One

  43. BULTUM ET, Roro EM, Wolde T, Regasa IF, et al
    Factors influencing exclusive breast feeding among children born to HIV positive mothers attending public health facilities in western Ethiopia: Cross-sectional study.
    PLoS One. 2022;17:e0271167.
    >> Share

  44. NKA AD, Ka'e AC, Bouba Y, Ngoufack Jagni Semengue E, et al
    Global burden of SARS-CoV-2 infection, hospitalization and case fatality rate among COVID-19 vaccinated individuals and its associated factors: A systematic review and meta-analysis protocol.
    PLoS One. 2022;17:e0272839.
    >> Share

  45. JONES M, Smith JC, Moore S, Newman A, et al
    Passion, commitment, and burnout: Experiences of Black gay men working in HIV/AIDS treatment and prevention in Atlanta, GA.
    PLoS One. 2022;17:e0264680.
    >> Share

  46. ANLEY DT, Akalu TY, Merid MW, Dessie AM, et al
    Development and validation of a nomogram for the prediction of late culture conversion among multi-drug resistant tuberculosis patients in North West Ethiopia: An application of prediction modelling.
    PLoS One. 2022;17:e0272877.
    >> Share

  47. BASENERO A, Neidel J, Ikeda DJ, Ashivudhi H, et al
    Integrating hypertension and HIV care in Namibia: A quality improvement collaborative approach.
    PLoS One. 2022;17:e0272727.
    >> Share

  48. LESHARGIE CT, Demant D, Burrowes S, Frawley J, et al
    The proportion of loss to follow-up from antiretroviral therapy (ART) and its association with age among adolescents living with HIV in sub-Saharan Africa: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0272906.
    >> Share

  49. BIZUNEH FK, Tolossa T, Bekonjo NE, Wakuma B, et al
    Time to recovery from severe acute malnutrition and its predictors among children aged 6-59 months at Asosa general hospital, Northwest Ethiopia. A retrospective follow up study.
    PLoS One. 2022;17:e0272930.
    >> Share


    PLoS Pathog

  50. FRANCIS AC, Cereseto A, Singh PK, Shi J, et al
    Localization and functions of native and eGFP-tagged capsid proteins in HIV-1 particles.
    PLoS Pathog. 2022;18:e1010754.
    >> Share


    Proc Natl Acad Sci U S A

  51. VELU V, Titanji K, Ahmed H, Shetty RD, et al
    PD-1 blockade following ART interruption enhances control of pathogenic SIV in rhesus macaques.
    Proc Natl Acad Sci U S A. 2022;119:e2202148119.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016